Obesity, leptin, and Alzheimer's disease

Obesity has various deleterious effects on health largely associated with metabolic abnormalities including abnormal glucose and lipid homeostasis that are associated with vascular injury and known cardiac, renal, and cerebrovascular complications. Advanced age is also associated with increased adiposity, decreased lean mass, and increased risk for obesity‐related diseases. Although many of these obesity‐ and age‐related disease processes have long been subsumed to be secondary to metabolic or vascular dysfunction, increasing evidence indicates that obesity also modulates nonvascular diseases such as Alzheimer's disease (AD) dementia. The link between peripheral obesity and neurodegeneration will be explored, using adipokines and AD as a template. After an introduction to the neuropathology of AD, the relationship between body weight, obesity, and dementia will be reviewed. Then, population‐based and experimental studies that address whether leptin modulates brain health and mitigates AD pathways will be explored. These studies will serve as a framework for understanding the role of adipokines in brain health.

[1]  H. Münzberg,et al.  Complex regulation of mammalian target of rapamycin complex 1 in the basomedial hypothalamus by leptin and nutritional status. , 2009, Endocrinology.

[2]  Mark A. Smith,et al.  Central obesity and increased risk of dementia more than three decades later. , 2009, Neurology.

[3]  M. Birnbaum,et al.  AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus , 2004, Nature.

[4]  Christina A. Wilson,et al.  GSK-3α regulates production of Alzheimer's disease amyloid-β peptides , 2003, Nature.

[5]  Kristine Yaffe,et al.  Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study , 2005, BMJ : British Medical Journal.

[6]  Xiao Man Yang,et al.  Leptin resistance during aging is independent of fat mass. , 2002, Diabetes.

[7]  Charles D. Smith,et al.  Human cerebral neuropathology of Type 2 diabetes mellitus. , 2009, Biochimica et biophysica acta.

[8]  D. Ingram,et al.  Caloric restriction attenuates amyloid deposition in middle-aged dtg APP/PS1 mice , 2009, Neuroscience Letters.

[9]  G. Barsh,et al.  AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. , 2007, The Journal of clinical investigation.

[10]  F. Liu,et al.  Regulation of amyloid precursor protein expression and secretion via activation of ERK1/2 by hepatocyte growth factor in HEK293 cells transfected with APP751. , 2003, Experimental cell research.

[11]  D. Bennett,et al.  Body mass index in older persons is associated with Alzheimer disease pathology , 2006, Neurology.

[12]  M. Albert,et al.  Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[13]  E. Barrett-Connor,et al.  Weight Loss Precedes Dementia in Community‐Dwelling Older Adults , 1996, The journal of nutrition, health & aging.

[14]  O. Mitchell,et al.  Perspectives from the President's Commission on Social Security Reform , 2003 .

[15]  P. Zandi,et al.  Vascular Risk Factors for Incident Alzheimer Disease and Vascular Dementia: The Cache County Study , 2006, Alzheimer disease and associated disorders.

[16]  R. Mayeux,et al.  Adiposity and Alzheimer's disease. , 2007, Current Alzheimer research.

[17]  S. Bouret,et al.  Hypothalamic neural projections are permanently disrupted in diet-induced obese rats. , 2008, Cell metabolism.

[18]  V. Lee,et al.  Constitutively active Akt inhibits trafficking of amyloid precursor protein and amyloid precursor protein metabolites through feedback inhibition of phosphoinositide 3-kinase. , 2009, Biochemistry.

[19]  P. Scarpace,et al.  Resistance to the anorexic and thermogenic effects of centrally administrated leptin in obese aged rats , 2000, Regulatory Peptides.

[20]  C. Mantzoros,et al.  Role of leptin in the neuroendocrine response to fasting , 1996, Nature.

[21]  P. Zandi,et al.  Adiposity indicators and dementia over 32 years in Sweden , 2009, Neurology.

[22]  S. Bandyopadhyay,et al.  Interleukin‐1α stimulates non‐amyloidogenic pathway by α‐secretase (ADAM‐10 and ADAM‐17) cleavage of APP in human astrocytic cells involving p38 MAP kinase , 2006 .

[23]  Christina A. Wilson,et al.  GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. , 2003, Nature.

[24]  J. Luchsinger,et al.  Adiposity, type 2 diabetes, and Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[25]  Joy Hirsch,et al.  Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. , 2008, The Journal of clinical investigation.

[26]  J. Harvey,et al.  Neuroprotective actions of leptin on central and peripheral neurons in vitro , 2008, Neuroscience.

[27]  E. Bullmore,et al.  Leptin Regulates Striatal Regions and Human Eating Behavior , 2007, Science.

[28]  K. Moar,et al.  Localization of leptin receptor (Ob-R) messenger ribonucleic acid in the rodent hindbrain. , 1998, Endocrinology.

[29]  Hirotaka Kosaka,et al.  Relationship Between Plasma Leptin Level and Brain Structure in Elderly: A Voxel-Based Morphometric Study , 2009, Biological Psychiatry.

[30]  C. Lominska,et al.  Increased amyloid- levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet. , 2002, The journal of nutrition, health & aging.

[31]  R. Stewart,et al.  A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. , 2005, Archives of neurology.

[32]  F. Zhang,et al.  Leptin protects hippocampal CA1 neurons against ischemic injury , 2008, Journal of neurochemistry.

[33]  F. van Leuven,et al.  A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease , 2005, Nutrition & metabolism.

[34]  M. Schwartz,et al.  Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons. , 2005, Cell metabolism.

[35]  M. Mattson,et al.  Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons , 2008, Nature Neuroscience.

[36]  Paul K Crane,et al.  Different patterns of cerebral injury in dementia with or without diabetes. , 2009, Archives of neurology.

[37]  R. Whitmer The epidemiology of adiposity and dementia. , 2007, Current Alzheimer research.

[38]  D. Bennett,et al.  Alzheimer disease in the US population: prevalence estimates using the 2000 census. , 2003, Archives of neurology.

[39]  A. Irving,et al.  Leptin Enhances NMDA Receptor Function and Modulates Hippocampal Synaptic Plasticity , 2001, The Journal of Neuroscience.

[40]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[41]  C. Rosano,et al.  Serum leptin level and cognition in the elderly: Findings from the Health ABC Study , 2009, Neurobiology of Aging.

[42]  P. Hof,et al.  The FASEB Journal express article 10.1096/fj.05-4359fje. Published online September 26, 2005. , 2022 .

[43]  P. Ritz,et al.  IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease. , 2007, The journal of nutrition, health & aging.

[44]  S. Sternson,et al.  Leptin targets in the mouse brain , 2009, The Journal of comparative neurology.

[45]  M. Seifert,et al.  Feedback inhibition of leptin receptor/Jak2 signaling via Tyr1138 of the leptin receptor and suppressor of cytokine signaling 3. , 2005, Molecular endocrinology.

[46]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[47]  Xiao-Ming Yin,et al.  Leptin Protects against 6-Hydroxydopamine-induced Dopaminergic Cell Death via Mitogen-activated Protein Kinase Signaling* , 2007, Journal of Biological Chemistry.

[48]  D. Bennett,et al.  Change in body mass index and risk of incident Alzheimer disease , 2005, Neurology.

[49]  K. Duff,et al.  Transgenic mouse models of Alzheimer's disease: how useful have they been for therapeutic development? , 2004, Briefings in functional genomics & proteomics.

[50]  M. Youdim,et al.  Non-steroidal Anti-inflammatory Drugs Stimulate Secretion of Non-amyloidogenic Precursor Protein* , 2002, The Journal of Biological Chemistry.

[51]  A. Irving,et al.  Leptin promotes rapid dynamic changes in hippocampal dendritic morphology , 2007, Molecular and Cellular Neuroscience.

[52]  J. Flier,et al.  Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. , 2000, The Journal of clinical investigation.

[53]  Bryan Maloney,et al.  Gene structure and organization of the human beta-secretase (BACE) promoter. , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  K. Yaffe,et al.  Body mass index in midlife and risk of Alzheimer disease and vascular dementia. , 2007, Current Alzheimer research.

[55]  J. Flier,et al.  Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function. , 1998, The Journal of clinical investigation.

[56]  T. Morgan,et al.  Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic models , 2005, Neurobiology of Aging.

[57]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[58]  Federal Inter-Agency Forum on Aging Related Stats Older Americans 2012: Key Indicators of Well-Being , 2012 .

[59]  M. Racchi,et al.  Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase‐dependent pathway , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[60]  P. Spano,et al.  Leptin Increases Axonal Growth Cone Size in Developing Mouse Cortical Neurons by Convergent Signals Inactivating Glycogen Synthase Kinase-3β* , 2006, Journal of Biological Chemistry.

[61]  Bryan Maloney,et al.  Gene structure and organization of the human β‐secretase (BACE) promoter , 2004 .

[62]  F. Pi‐Sunyer,et al.  Obesity‐related leptin regulates Alzheimer's Aβ , 2004 .

[63]  F. Pi-Sunyer,et al.  Obesity-related leptin regulates Alzheimer's Abeta. , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[64]  J. Friedman,et al.  Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[65]  F. Liu,et al.  Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing. , 2004, Biochemistry.

[66]  J. Hess,et al.  Differential expression of mRNA for leptin receptor isoforms in the rat brain , 1997, Molecular and Cellular Endocrinology.

[67]  R Brookmeyer,et al.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.

[68]  M. Tabaton,et al.  JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1 , 2009, Neurobiology of Aging.

[69]  Nick C Fox,et al.  The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .

[70]  J. Flier,et al.  Identification of SOCS-3 as a potential mediator of central leptin resistance. , 1998, Molecular cell.

[71]  P. Spano,et al.  Leptin Is Induced in the Ischemic Cerebral Cortex and Exerts Neuroprotection Through NF-&kgr;B/c-Rel–Dependent Transcription , 2009, Stroke.

[72]  George Perry,et al.  The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s Disease , 2002, Neurosignals.

[73]  Xiao Man Yang,et al.  Aging is associated with resistance to effects of leptin on fat distribution and insulin action. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.

[74]  S. Bandyopadhyay,et al.  Interleukin-1alpha stimulates non-amyloidogenic pathway by alpha-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase. , 2006, Journal of neuroscience research.

[75]  Suzanne Craft,et al.  The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. , 2009, Archives of neurology.

[76]  P. Reiner,et al.  Regulation of Amyloid Precursor Protein Catabolism Involves the Mitogen-Activated Protein Kinase Signal Transduction Pathway , 1997, The Journal of Neuroscience.

[77]  M. Nicolson,et al.  Leptin Gene Expression Increases With Age Independent of Increasing Adiposity in Rats , 1997, Diabetes.

[78]  J. Parisi,et al.  The Long Form of the Leptin Receptor (OB-Rb) Is Widely Expressed in the Human Brain , 2000, Neuroendocrinology.

[79]  C. Saper,et al.  Distributions of leptin receptor mRNA isoforms in the rat brain , 1998, The Journal of comparative neurology.

[80]  B. Neel,et al.  Neuronal PTP1B regulates body weight, adiposity and leptin action , 2006, Nature Medicine.

[81]  A. Arco,et al.  Decreased leptin uptake in hypothalamic nuclei with ageing in Wistar rats. , 2000, The Journal of endocrinology.

[82]  G. Bray,et al.  HF diets increase hypothalamic PTP1B and induce leptin resistance through both leptin-dependent and -independent mechanisms. , 2009, American journal of physiology. Endocrinology and metabolism.

[83]  D. Carling,et al.  AMP-activated Protein Kinase Plays a Role in the Control of Food Intake* , 2004, Journal of Biological Chemistry.

[84]  Steven J. Greco,et al.  Leptin inhibits glycogen synthase kinase-3β to prevent tau phosphorylation in neuronal cells , 2009, Neuroscience Letters.

[85]  G. Multhaup,et al.  IGF-1-induced Processing of the Amyloid Precursor Protein Family Is Mediated by Different Signaling Pathways* , 2007, Journal of Biological Chemistry.

[86]  Jun Wang,et al.  Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology. , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[87]  R. Ahima,et al.  Postnatal regulation of hypothalamic neuropeptide expression by leptin: implications for energy balance and body weight regulation , 2000, Regulatory Peptides.

[88]  P. Hof,et al.  Caloric restriction attenuates β‐amyloid neuropathology in a mouse model of Alzheimer's disease , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[89]  Alexander S. Banks,et al.  Regulation of Jak Kinases by Intracellular Leptin Receptor Sequences* , 2002, The Journal of Biological Chemistry.

[90]  H. Arai,et al.  Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer’s disease , 2011, European journal of neurology.

[91]  S. Gandy,et al.  The Phosphatidylinositol 3‐Kinase Inhibitor Wortmannin Alters the Metabolism of the Alzheimer's Amyloid Precursor Protein , 1999, Journal of neurochemistry.

[92]  S. Bouret,et al.  Trophic Action of Leptin on Hypothalamic Neurons That Regulate Feeding , 2004, Science.

[93]  A. Sahu,et al.  A phosphatidylinositol 3-kinase–phosphodiesterase 3B–cyclic AMP pathway in hypothalamic action of leptin on feeding , 2002, Nature Neuroscience.

[94]  O. Ghribi,et al.  Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices. , 2010, Journal of Alzheimer's disease : JAD.

[95]  E. Kojro,et al.  The neuropeptide PACAP promotes ?‐secretase pathway for processing Alzheimer amyloid precursor protein , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[96]  M. Azain,et al.  Increased Leptin Resistance as Rats Grow to Maturity , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[97]  Richard Mayeux,et al.  Central Obesity in the Elderly is Related to Late-onset Alzheimer Disease , 2012, Alzheimer disease and associated disorders.

[98]  Bin Zhang,et al.  Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform , 1999, Neuron.

[99]  Patrick R Hof,et al.  Dietary composition modulates brain mass and solubilizable Aβ levels in a mouse model of aggressive Alzheimer's amyloid pathology , 2009, Molecular Neurodegeneration.

[100]  W. Brooks,et al.  Reduced lean mass in early Alzheimer disease and its association with brain atrophy. , 2010, Archives of neurology.

[101]  S. Woods,et al.  Leptin Receptor Long-form Splice-variant Protein Expression in Neuron Cell Bodies of the Brain and Co-localization with Neuropeptide Y mRNA in the Arcuate Nucleus , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[102]  M. Mattson,et al.  Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease , 2007, Neurobiology of Disease.

[103]  Katherine M Flegal,et al.  Obesity among adults in the United States--no statistically significant change since 2003-2004. , 2007, NCHS data brief.

[104]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[105]  Ling Li,et al.  Intake of Sucrose-sweetened Water Induces Insulin Resistance and Exacerbates Memory Deficits and Amyloidosis in a Transgenic Mouse Model of Alzheimer Disease* , 2007, Journal of Biological Chemistry.

[106]  J. Carvalheira,et al.  Cross-talk between the insulin and leptin signaling systems in rat hypothalamus. , 2005, Obesity research.

[107]  Ryuichi Morishita,et al.  Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes , 2010, Proceedings of the National Academy of Sciences.

[108]  Alexander S. Banks,et al.  Activation of Downstream Signals by the Long Form of the Leptin Receptor* , 2000, The Journal of Biological Chemistry.

[109]  Age , 2000, BMJ : British Medical Journal.

[110]  N. Barzilai,et al.  Central resistance to the inhibitory effects of leptin on stimulated insulin secretion with aging , 2006, Neurobiology of Aging.

[111]  M. Mattson,et al.  Leptin-mediated Cell Survival Signaling in Hippocampal Neurons Mediated by JAK STAT3 and Mitochondrial Stabilization* , 2008, Journal of Biological Chemistry.

[112]  Wei Zhang,et al.  Leptin Increases Adult Hippocampal Neurogenesis in Vivo and in Vitro* , 2008, Journal of Biological Chemistry.

[113]  F. Zhang,et al.  Neuroprotective Effects of Leptin Against Ischemic Injury Induced by Oxygen-Glucose Deprivation and Transient Cerebral Ischemia , 2007, Stroke.

[114]  Steven J. Greco,et al.  Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[115]  M. Ros,et al.  Ageing increases SOCS-3 expression in rat hypothalamus: effects of food restriction. , 2002, Biochemical and biophysical research communications.

[116]  F. Calon,et al.  High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model , 2010, Neurobiology of Aging.

[117]  G. Perry,et al.  β‐Site APP cleaving enzyme up‐regulation induced by 4‐hydroxynonenal is mediated by stress‐activated protein kinases pathways , 2005, Journal of neurochemistry.

[118]  Steven J. Greco,et al.  Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells. , 2009, Biochemical and biophysical research communications.

[119]  P. Greengard,et al.  Stimulation of β-Amyloid Precursor Protein Trafficking by Insulin Reduces Intraneuronal β-Amyloid and Requires Mitogen-Activated Protein Kinase Signaling , 2001, The Journal of Neuroscience.

[120]  A. Irving,et al.  Leptin inhibits epileptiform‐like activity in rat hippocampal neurones via PI 3‐kinase‐driven activation of BK channels , 2002, The Journal of physiology.

[121]  Hilkka Soininen,et al.  Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. , 2005, Archives of neurology.

[122]  N. Hooper,et al.  Muscarine enhances soluble amyloid precursor protein secretion in human neuroblastoma SH-SY5Y by a pathway dependent on protein kinase C(alpha), src-tyrosine kinase and extracellular signal-regulated kinase but not phospholipase C. , 2002, Brain research. Molecular brain research.

[123]  S. Heck,et al.  Estrogen induces a rapid secretion of amyloid beta precursor protein via the mitogen-activated protein kinase pathway. , 2001, European journal of biochemistry.

[124]  Lewis H Kuller,et al.  Midlife and late-life obesity and the risk of dementia: cardiovascular health study. , 2009, Archives of neurology.

[125]  M. Wong,et al.  Leptin Replacement Improves Cognitive Development , 2008, PloS one.

[126]  L. Miles,et al.  2000 , 2000, RDH.

[127]  Bryan Maloney,et al.  Transcriptional Regulation of β-Secretase by p25/cdk5 Leads to Enhanced Amyloidogenic Processing , 2008, Neuron.

[128]  C. Bouras,et al.  Expression of leptin receptor mRNA (long form splice variant) in the human cerebellum , 1997, Neuroreport.

[129]  Steven J. Greco,et al.  Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells. , 2008, Biochemical and biophysical research communications.

[130]  T. Fernández-Agulló,et al.  Changes in the neuroendocrine control of energy homeostasis by adiposity signals during aging , 2009, Experimental Gerontology.

[131]  J. Flier,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society Regulation of Neuronal and Glial Proteins by Leptin: Implications for Brain Development* , 2022 .

[132]  J. Trojanowski,et al.  Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease , 2012, Neurobiology of Aging.

[133]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[134]  S. Lin,et al.  Localization of leptin receptor mRNA expression in mouse brain. , 1996, Neuroreport.

[135]  W. Markesbery,et al.  Effects of short‐term Western diet on cerebral oxidative stress and diabetes related factors in APP × PS1 knock‐in mice , 2009, Journal of neurochemistry.

[136]  D. Lawrence,et al.  Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age. , 2007, Endocrinology.

[137]  R. L. Moore,et al.  Impaired leptin responsiveness in aged rats. , 2000, Diabetes.

[138]  Edythe D. London,et al.  Leptin replacement alters brain response to food cues in genetically leptin-deficient adults , 2007, Proceedings of the National Academy of Sciences.

[139]  J. Flier,et al.  SOCS3 Mediates Feedback Inhibition of the Leptin Receptor via Tyr985 * , 2000, The Journal of Biological Chemistry.

[140]  Chien-Jen Chen,et al.  Midlife risk factors for subtypes of dementia: a nested case-control study in Taiwan. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[141]  Zhenguo Wu,et al.  Tyk2/STAT3 Signaling Mediates β-Amyloid-Induced Neuronal Cell Death: Implications in Alzheimer's Disease , 2010, The Journal of Neuroscience.

[142]  A. Hulting,et al.  Expression of leptin receptor mRNA in the hypothalamic arcuate nucleus - relationship with NPY neurones , 1996, Neuroreport.

[143]  B. Ahrén,et al.  Regulation of plasma leptin in mice: influence of age, high-fat diet, and fasting. , 1997, The American journal of physiology.

[144]  E. Barrett-Connor,et al.  Central obesity and increased risk of dementia more than three decades later , 2008, Neurology.

[145]  M. Matheny,et al.  Hypothalamic leptin resistance is associated with impaired leptin signal transduction in aged obese rats , 2001, Neuroscience.

[146]  R. Tanzi,et al.  The Genetics of Alzheimer Disease: Back to the Future , 2010, Neuron.

[147]  Sudha Seshadri,et al.  Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. , 2009, JAMA.

[148]  Young-Bum Kim,et al.  PTP1B regulates leptin signal transduction in vivo. , 2002, Developmental cell.

[149]  J. Trojanowski,et al.  Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.

[150]  M. Mattson,et al.  Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice , 2009, Hippocampus.

[151]  M. Matheny,et al.  Aged-obese rats exhibit robust responses to a melanocortin agonist and antagonist despite leptin resistance , 2004, Neurobiology of Aging.

[152]  J. Flier,et al.  Divergent Roles of SHP-2 in ERK Activation by Leptin Receptors* , 2001, The Journal of Biological Chemistry.

[153]  B. Neel,et al.  Protein-tyrosine Phosphatase 1B Expression Is Induced by Inflammation in Vivo* , 2008, Journal of Biological Chemistry.

[154]  Patrick R Hof,et al.  Diet‐induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[155]  John A Matochik,et al.  Effect of leptin replacement on brain structure in genetically leptin-deficient adults. , 2005, The Journal of clinical endocrinology and metabolism.

[156]  Young-Bum Kim,et al.  Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature.

[157]  Heike Münzberg,et al.  Mechanisms of leptin action and leptin resistance. , 2008, Annual review of physiology.

[158]  Deborah Gustafson,et al.  An 18-year follow-up of overweight and risk of Alzheimer disease. , 2003, Archives of internal medicine.

[159]  B. Kennedy,et al.  Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. , 2002, Developmental cell.

[160]  R. Unger,et al.  The role of leptin resistance in the lipid abnormalities of aging , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[161]  A. Paul,et al.  Adipocytokines and CD34+ Progenitor Cells in Alzheimer's Disease , 2011, PloS one.